Podium to Practice: ASH® 2025 – MULTIPLE MYELOMA: TecLILLE trial, cohort a
OR
[magic_login_form]
Explore more from your favourite experts – click their name to access their entire library of content.
Chair
Studies / Trials Discussed
ID 367 – A phase 2 Study of teclistamab in combination with daratumumab in elderly patients with newly diagnosed multiple myeloma: The IFM2021-01 teclille trial, cohort a
Studies/trials discussed:
ID 367 – A phase 2 Study of teclistamab in combination with daratumumab in elderly patients with newly diagnosed multiple myeloma: The IFM2021-01 teclille trial, cohort a
Login to view content
PLease Enter Your Email to view Content
Pre-Video Survey
By continuing to watch the video, you consent to receiving a post-view survey by email.